Jailendra Singh
Stock Analyst at Truist Securities
(0.86)
# 3,732
Out of 4,873 analysts
174
Total ratings
26.37%
Success rate
-25.52%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Initiates: Buy | $48 | $44.53 | +7.79% | 1 | Jun 16, 2025 | |
| PHR Phreesia | Maintains: Buy | $34 → $35 | $27.61 | +26.77% | 6 | May 29, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $9 | $7.57 | +18.89% | 16 | May 27, 2025 | |
| DOCS Doximity | Maintains: Hold | $58 → $52 | $60.17 | -13.58% | 8 | May 16, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $45 → $50 | $39.00 | +28.21% | 2 | May 8, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $333 → $300 | $311.14 | -3.58% | 4 | Apr 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $263 → $216 | $158.71 | +36.10% | 15 | Apr 10, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $262 → $208 | $145.91 | +42.55% | 9 | Apr 10, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $27 → $28 | $21.75 | +28.74% | 7 | Apr 10, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $39 → $33 | $41.41 | -20.31% | 9 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.91 | +12.02% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $10.71 | +30.72% | 5 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $7.41 | +1.21% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $25.04 | +83.71% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $279.50 | -24.87% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $26 → $19 | $20.91 | -9.13% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.60 | +11.11% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $2.18 | +198.17% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.20 | +209.52% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $7.86 | +447.07% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.84 | +525.00% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.30 | +73.91% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $163.75 | -64.58% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $5.51 | +716.70% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $718.41 | -53.65% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.74 | +228.47% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $21.86 | - | 3 | Jan 15, 2021 |
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $44.53
Upside: +7.79%
Phreesia
May 29, 2025
Maintains: Buy
Price Target: $34 → $35
Current: $27.61
Upside: +26.77%
Teladoc Health
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.57
Upside: +18.89%
Doximity
May 16, 2025
Maintains: Hold
Price Target: $58 → $52
Current: $60.17
Upside: -13.58%
Waystar Holding
May 8, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $39.00
Upside: +28.21%
Medpace Holdings
Apr 23, 2025
Maintains: Hold
Price Target: $333 → $300
Current: $311.14
Upside: -3.58%
IQVIA Holdings
Apr 10, 2025
Maintains: Buy
Price Target: $263 → $216
Current: $158.71
Upside: +36.10%
ICON Public Limited Company
Apr 10, 2025
Maintains: Buy
Price Target: $262 → $208
Current: $145.91
Upside: +42.55%
Privia Health Group
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $21.75
Upside: +28.74%
Hims & Hers Health
Apr 10, 2025
Maintains: Hold
Price Target: $39 → $33
Current: $41.41
Upside: -20.31%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.91
Upside: +12.02%
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $10.71
Upside: +30.72%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.41
Upside: +1.21%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $25.04
Upside: +83.71%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $279.50
Upside: -24.87%
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $20.91
Upside: -9.13%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.60
Upside: +11.11%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $2.18
Upside: +198.17%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.20
Upside: +209.52%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $7.86
Upside: +447.07%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.84
Upside: +525.00%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.30
Upside: +73.91%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $163.75
Upside: -64.58%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $5.51
Upside: +716.70%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $718.41
Upside: -53.65%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.74
Upside: +228.47%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $21.86
Upside: -